ORCHARD PARK, N.Y., Feb. 6 /PRNewswire-FirstCall/ -- MINRAD International, Inc. (AMEX:BUF) -- On February 2, 2009, the Company received a notice from NYSE Alternext US LLC (the "Exchange...
- Combined company will create a global company in inhaled anaesthetic gas products - MUMBAI, India, Dec. 22 /PRNewswire-FirstCall/ -- Piramal Healthcare Limited [NSE: Pirhealth, BSE: 500302]...
ORCHARD PARK, N.Y., Dec. 17 /PRNewswire-FirstCall/ -- MINRAD International, Inc. (AMEX:BUF) today reported that the Company received a notice from NYSE Alternext US LLC (the "Exchange") stating...
ORCHARD PARK, N.Y., Nov. 25 /PRNewswire-FirstCall/ -- MINRAD International, Inc. (AMEX:BUF) today announced that it has terminated its Distribution Agreement for anesthetics for the human market...
ORCHARD PARK, N.Y., Nov. 20 /PRNewswire-FirstCall/ -- MINRAD International, Inc. (AMEX:BUF), announced effective today it will reduce its workforce by approximately 35% or 50 positions. Dave...
ORCHARD PARK, N.Y., Nov. 19 /PRNewswire-FirstCall/ -- MINRAD International, Inc. (AMEX:BUF), announced today the Company will hold an investor conference call to discuss current business...
Summary: ORCHARD PARK, N.Y., Nov. 14 /PRNewswire-FirstCall/ -- MINRAD International, Inc. (AMEX:BUF), an interventional pain management company, today reported revenue of $7.1 million for the...
ORCHARD PARK, N.Y., Sept. 11 /PRNewswire-FirstCall/ -- MINRAD International, Inc. (AMEX:BUF) today announced that it has notified RxElite Holdings, Inc., a wholly-owned subsidiary of RxElite...
ORCHARD PARK, N.Y., Aug. 14 /PRNewswire-FirstCall/ -- Summary: -- Revenue of $ 4.2 million compared to $4.3 million for the second quarter of 2007. -- Operating loss of $6.3 million...
ORCHARD PARK, N.Y., Aug. 4 /PRNewswire-FirstCall/ -- MINRAD International, Inc. (AMEX:BUF) announced today that the Company will hold an investor conference call to discuss second quarter 2008...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
Aucune Discussion Trouvée |
Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales